Soft Agar Colony Formation Assay

Principle

Soft agar colony formation assay measures anchorage-independent growth, in which transformed or tumorigenic cells proliferate as colonies in a semisolid agar matrix while many non-transformed adherent cells fail to proliferate without attachment; classic studies showed that growth in semisolid medium correlates with tumorigenicity in nude mice, and later protocol papers describe the method as a stringent in vitro assay for malignant transformation[1][2][3][4]. The readout is the number, size, morphology, or signal intensity of colonies formed within agar after incubation; published formats include manual colony counting after staining, 96-well or 384-well quantitative formats, DNA-binding dye detection, MTT/tetrazolium-based detection, digital image analysis, and PCR-based marker detection from soft agar cultures[3][5][6][7][8][9][10].

MCE has not independently verified the accuracy of these methods. They are for reference only.

Experimental Materials

Use agar or agarose to form the non-adherent semisolid matrix, complete culture medium with serum to support cell growth, sterile PBS or medium for washing and overlay, trypsin-EDTA for adherent-cell dissociation, and test compounds or genetic perturbation conditions only when the experimental question requires treatment comparison[3][5][6][9][10].

Reported agar concentrations vary by format: examples include a bottom/base layer around 0.5-0.6% agar/agarose and a cell-containing top layer around 0.3-0.4% agar/agarose; therefore, the selected concentration should be matched to the cited format and cell type rather than generalized across all models[3][5][9][10].

Crystal violet has been used to stain colonies for visualization and manual counting, CyQUANT/DNA-binding dye formats quantify cellular DNA in soft agar cultures, MTT/tetrazolium formats provide metabolic colorimetric readouts, and qPCR can detect proliferation-related or cancer-stem-cell marker transcripts from soft agar cultures when molecular characterization is the endpoint[3][6][7][8][9].

Use sterile tissue-culture plates or dishes, a 37 °C/5% CO2 incubator, water bath or heating block for agar handling, microscope or imaging system for colony inspection, colony-counting or image-analysis software when automated quantification is used, microplate reader for fluorescence or absorbance assays, and qPCR equipment when PCR-based readout is used[3][5][6][7][8][9][10].

Experimental Procedure

Maintain cells under standard culture conditions until healthy and proliferative, dissociate adherent cells into a single-cell suspension, count viable cells, and prepare the cell density required for the selected plate format; published examples include 6-well manual assays, 96-well quantitative assays, 384-well screening assays, and cell-mixture sensitivity assays using HeLa cells spiked into non-tumorigenic cells[3][5][6][7][9][10].

Prepare molten agar or agarose and equilibrate it with warm complete medium before plating, because the method requires a solidified base layer to prevent attachment and a softer upper layer containing suspended cells; reported formats commonly pour or dispense the base layer first, allow it to solidify, then overlay the cell-containing agar layer[3][5][9][10].

Add the base agar layer to the plate and allow it to solidify; examples include 96-well assays using 50 µL of 0.6% agar in complete DMEM chilled to solidify, and other protocol formats using approximately 0.5-0.6% base agar/agarose in complete medium[3][9][10].

Mix the single-cell suspension with molten agar/agarose-containing complete medium to form the cell-containing top layer; reported examples include 75 µL of 0.4% cell agar in 96-well plates, 0.3% agarose cell layers in breast-cancer inhibitor assays, and approximately 0.35% soft agarose cell layers in published colony-formation examples[5][9][10].

After the cell-containing agar layer solidifies, add complete medium above the agar and incubate at 37 °C with 5% CO2; reported incubation periods include 6-8 days for some 96-well quantitative kits and short-term formats, 14-21 days for many cancer-cell colony-counting assays, 20 days for conventional detection of HeLa contamination in hMSCs, and 30 days for digital ultrasensitive detection[3][5][6][7][9][10].

For treatment studies, add vehicle and treatment conditions consistently to the overlay medium or agar-containing layer as described in the selected study design; Horibata and colleagues used the assay to test the PADI inhibitor BB-Cl-amidine against breast cancer cell tumorigenicity, and high-throughput studies used soft agar formats to compare compound effects in three-dimensional anchorage-independent growth assays[5][7].

For manual readout, stain colonies when the incubation endpoint is reached, image wells or dishes, and count colonies; colony number and colony size are interpreted as measures of anchorage-independent proliferative capacity, and reduced colony formation after a genetic or drug perturbation is interpreted as reduced anchorage-independent growth under the tested condition[3][5][10].

For quantitative readouts, measure fluorescence for DNA-binding dye assays, absorbance for tetrazolium/MTT assays, or qPCR marker expression after extracting material from soft agar; Nakamura reported Ki-67 and cyclin B mRNA detection of 0.01% HeLa cells after 5 days, CDK1 detection after 2 weeks, and ALDH1/CD133 marker detection at later time points, while noting that CDK2, PCNA, MCM7, and CD44 were not useful markers in that model[6][8][9].

Include negative controls without cells or with non-tumorigenic cells, positive controls with a known colony-forming transformed/tumorigenic cell line, and vehicle controls for compound studies; Nakamura used MRC-5 as a non-tumorigenic negative control and HeLa as a tumorigenic positive control, while Kusakawa used HeLa-spiked hMSC mixtures to evaluate detection sensitivity[6][8][9].

Use biological replicates and statistical comparison when reported by the study design; Nakamura reported triplicate samples and used LLOD criteria based on the mean expression of MRC-5 controls plus 3.3 standard deviations, while image-based and high-throughput formats quantify colony counts or signal intensity across wells for comparative analysis[6][7][8][9].

Troubleshooting

Problem: Colonies are difficult to distinguish from non-proliferative cell clumps.

Possible Cause: Normal cells or high-density cultures may aggregate in soft agar without true anchorage-independent proliferation.
Literature-supported Solution: Use appropriate positive and negative control cell lines, image-based or molecular confirmation where needed, and interpret colonies cautiously because Nakamura observed MRC-5 aggregates that were not distinguishable from HeLa colonies by morphology alone at 1 week[8].

Problem: Manual counting is subjective or low-throughput.

Possible Cause: Colony size varies and dense three-dimensional growth makes visual scoring difficult.
Literature-supported Solution: Use quantitative fluorescence, absorbance, automated imaging, digital analysis, or high-throughput plate formats when the research question requires scalable or less subjective quantification[6][7][9].

Problem: The assay is too slow for early screening.

Possible Cause: Conventional visual or DNA-staining soft agar assays may require about 20-30 days depending on endpoint and sensitivity requirements.
Literature-supported Solution: Use validated short-format quantitative approaches only when matched to the endpoint, such as 6-8 day 96-well detection formats or qPCR detection of selected proliferation transcripts after 5 days in the specific HeLa/MRC-5 model[8][9].

References: